Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In breast cancer, the presence of nodal metastases is a key indicator of poorer overall survival. The aim of this study was to identify somatic genetic alterations in early dissemination of breast cancer by whole genome next generation sequencing (NGS) of a primary breast tumor, a matched locally-involved axillary lymph node and healthy normal DNA from blood.Whole genome NGS was performed on 12 µg (range 11.1–13.3 µg) of DNA isolated from fresh-frozen primary breast tumor, axillary lymph node and peripheral blood following the DNA nanoball sequencing protocol. Single nucleotide variants, insertions, deletions, and substitutions were identified through a bi...
Cancer related mortality is almost always due to metastatic dissemination of the primary disease. Wh...
Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemic treatm...
The sequencing of cancer genomes may enable tailoring of therapeutics to the underlying biological a...
Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In breast canc...
<div><p>Background</p><p>Intratumoral heterogeneity may help drive resistance to targeted therapies ...
Background: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. I...
Background: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. I...
" These authors are joint first authors on this work. Background: Intratumoral heterogeneity ma...
BACKGROUND: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In...
Breast cancer is one of the leading causes of cancer mortality worldwide. Distant metastases are nea...
<div><p>Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemi...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple ...
Recent advances in next generation sequencing have made it possible to precisely characterize all so...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemic treatm...
Cancer related mortality is almost always due to metastatic dissemination of the primary disease. Wh...
Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemic treatm...
The sequencing of cancer genomes may enable tailoring of therapeutics to the underlying biological a...
Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In breast canc...
<div><p>Background</p><p>Intratumoral heterogeneity may help drive resistance to targeted therapies ...
Background: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. I...
Background: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. I...
" These authors are joint first authors on this work. Background: Intratumoral heterogeneity ma...
BACKGROUND: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In...
Breast cancer is one of the leading causes of cancer mortality worldwide. Distant metastases are nea...
<div><p>Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemi...
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple ...
Recent advances in next generation sequencing have made it possible to precisely characterize all so...
Several studies using genome-wide molecular techniques have reported various degrees of genetic hete...
Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemic treatm...
Cancer related mortality is almost always due to metastatic dissemination of the primary disease. Wh...
Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemic treatm...
The sequencing of cancer genomes may enable tailoring of therapeutics to the underlying biological a...